Skip to Content
Merck
CN

228672

Samarium(III) oxide

99.9% trace metals basis

Synonym(s):

Samarium oxide, Samaria

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
Sm2O3
CAS Number:
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352303
EC Number:
235-043-6
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

99.9% trace metals basis

form

powder

reaction suitability

reagent type: catalyst
core: samarium

density

8.35 g/mL at 25 °C (lit.)

SMILES string

O=[Sm]O[Sm]=O

InChI

1S/3O.2Sm

InChI key

PRCWVHVINXAFRG-UHFFFAOYSA-N



Still not finding the right product?

Explore all of our products under Samarium(III) oxide


Storage Class

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

监管及禁止进口产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



S F Ahrabi et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 8(3), 193-201 (1999-06-24)
The effect of the neutron activation factors, i.e., admixture of samarium oxide (Sm2O3) and irradiation time, on the physico-chemical properties of the raw materials and the in vitro dissolution and disintegration of hydrophilic and lipophilic suppositories was investigated. It was
Lloyd G Tillman et al.
Journal of pharmaceutical sciences, 97(1), 225-236 (2007-08-28)
Treatment of systemic disease with phosphorothioate antisense oligonucleotides (PS ASOs) has been accomplished using local or parenteral routes of administration to date. This report describes, for the first time, the effective oral delivery of a second generation oligonucleotide where significant
Matthew D Burke et al.
Pharmaceutical research, 24(4), 695-704 (2007-03-21)
To develop a robust radiolabeling technique to enable evaluation of difficult to radiolabel gastric retentive formulations using gamma scintigraphy. The use of a successful radiolabel will allow accurate assessment of the gastric residence time of the formulations. The retention of



Global Trade Item Number

SKUGTIN
228672-100G04061838781314
228672-10G04061838781321